Navigation Links
NSAIDs: Take 'em early and often when competing? Think again

Athletes' superstitions and rituals can help them get psyched up for contests, but when these rituals involve non-steroidal anti-inflammatory drugs (NSAIDs), which many athletes gobble down before and during events, they could be causing more harm than good.

"These agents are treatments for the symptoms of an injury, not the injury itself," says Stuart Warden, whose research at Indiana University focuses on musculoskeletal health and sports medicine. "They may allow an athlete to exercise or train at a certain level, but pain occurs for a reason. It is basically the body's mechanism of saying, 'Hang on, you've got some sort of injury that should not be ignored.'"

NSAIDs are recommended for use after an injury to reduce swelling or pain. Studies have found that many elite athletes, however, take these over-the-counter drugs -- and often several different kinds -- before contests and challenging workouts because they think they will reduce anticipated inflammation and soreness that could occur after the event.

Warden says there is no scientific evidence for this prophylactic use of NSAIDs. Such misuse, however, can cause a range of problems, from interfering with healing and inhibiting the body's ability to adapt to challenging workouts, to the development of stomach ulcers and possibly an increased risk for cardiovascular problems, says Warden, assistant professor in the Department of Physical Therapy at Indiana University-Purdue University Indianapolis.

The larger the dose and the longer duration of NSAID use, the greater potential for these risks. Warden warned against the misuse of NSAIDs in an editorial published earlier this year in the "British Journal of Sports Medicine."

"I want people, including recreational athletes, to think about the perceived benefits versus potential risks of taking NSAIDs, and to ask themselves why they are taking these agents," said Warden. "They need to ask, 'Do the benefits outweigh the risks?"

  • Background. NSAIDs interact with the body's chemistry at a cellular level by inhibiting the cyclooxygenase (COX) isozymes. The COX isozymes are critical for the synthesis of prostaglandins, which have important functions in the gut and cardiovascular system, as well as during inflammation and the adaptive response of the musculoskeletal system to stress. NSAIDs may reduce pain and inflammation following injury by inhibiting COX isozyme-induced prostaglandin synthesis; however, as they circulate within the body indiscriminately, rather than localizing to the source of an athlete's specific aches and pains, they may produce undesirable side effects. With regular misuse, athletes face extreme and severe risks, such as the development of ulcers, potentially fatal problems with renal blood flow, and increased risks for cardiovascular problems. On a lesser scale, they could actually increase their risk for injuries because their bodies are less able to adapt to rigorous workouts -- and healing could take longer.

    Warden said NSAIDs should be taken as directed -- in the recommended dosages and for no more than a week after an acute injury that involves swelling and pain.

    "But to take the drugs before every run and throughout the year is a concern. You need to think of pain not as a hindrance, but as a signal that something is not quite right," he says, adding that, "NSAIDs should not be used at the expense of a thorough assessment of an injury by a trained professional, such as a physical therapist or physician."


  • Contact: Stuart Warden
    Indiana University

    Related biology news :

    1. Study shows nearly 1/3 of human genome is involved in gingivitis
    2. Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy
    3. UNH prof. receives nearly $500,000 to research environmentally significant plants
    4. Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics
    5. Early life on Earth may have developed more quickly than thought
    6. Stimulus grant of nearly $9 million to UC San Diego funds big study of young brains
    7. JCI online early table of contents: Oct. 12, 2009
    8. Banded rocks reveal early Earth conditions, changes
    9. Early hominid first walked on 2 legs in the woods
    10. US needs nearly $200 million more on climate-related health research
    11. Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccine
    Post Your Comments:
    (Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
    (Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
    (Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
    Breaking Biology News(10 mins):
    (Date:11/23/2015)... --  Ceres, Inc . (Nasdaq: CERE ), an ... fiscal year ended August 31, 2015 and provided an ... --> During fiscal year 2015, Ceres refocused ... a better balance of yield, energy and nutrition. Among ... leading crop input providers and made significant progress in ...
    (Date:11/23/2015)... ... November 23, 2015 , ... Shimadzu ... of its Nexera UC Unified Chromatography system. The award from R&D magazine recognizes ... products of the year in the analytical and testing category. R&D Magazine chose ...
    (Date:11/23/2015)... GENEVA , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... licence for a hepatitis C medicine, signing an agreement with ... proven to help cure multiple genotypes of the HCV virus. ...
    (Date:11/23/2015)... -- biochar market is estimated to ... is expected to grow with a CAGR of 17.1% ... of the global market include improved soil fertility and ... government initiatives and stringent environmental regulations, and waste management ... are the key drivers for the growth of the ...
    Breaking Biology Technology: